C2h.niph.go.jp

C2H｜Center for Outcomes Research and Economic …

WebC2H is the first public research organization for official cost-effectiveness evaluation process in Japan. We provide data and materials for evidence-based health policy (EBPH). The …

Actived: 6 days ago

URL: https://c2h.niph.go.jp/en/

Concept of cost-effectiveness evaluation C2H｜Center …

WebWhen we argue about cost-effectiveness of healthcare, it would not be correct to say: “The cheaper, the better.” What is important is the balance between cost and outcome. How …

Category: Health Go Health

Price setting of medicines and medical devices

WebIn Japan, manufacturers cannot freely decide the prices of medicines and medical devices provided under the public health insurance. The prices are decided by the Ministry of …

Category: Medical, Medicine Go Health

Roles of C2H in cost-effectiveness evaluation

WebThe Center for Outcomes Research and Economic Evaluation for Health (C2H) was founded in 2018 for academic research on cost-effectiveness evaluation, and public roles …

Category: Health Go Health

Application of cost-effectiveness evaluation in Japan

WebHowever, application of cost-effectiveness data advanced on a global scale. In the UK., NICE was founded in 1999 and began to actively use information on cost-effectiveness …

Category: Health Go Health

Guideline, notifications and others

WebFukuda T and Shiroiwa T. Application of economic evaluation of pharmaceuticals and medical devices in Japan. J. Natl. Inst. Public Health. 2019;8(1):27-33.

Category: Medical Go Health

Evaluation of costs in cost-effectiveness evaluation

WebI have stated in the preceding section that when discussing cost-effectiveness, it is important to assess both the cost and outcome. Then, how should the magnitude of these two …

Category: Health Go Health

International symposium

WebDate and Time: Monday, February 25, 2019 1 pm to 5:30 pm Theme: Current Status and Future Role of HTA in Japan and Other Countries Venue：The GRAND …

Category: Health Go Health

Guideline for Preparing Cost-Effectiveness Evaluation to the …

Web5 2 Perspective 2.1 The perspective of the analysis should be specified. In particular, the perspective determines the costs to be included. 2.2 “Public healthcare payer’s …

Category: Health Go Health

Guideline for Preparing

Web3.1.1 In the case that a new indication is approved between the selection of target technology and the determination of the framework of analysis, it is to be included in the …

Category: Health Go Health

News C2H｜Center for Outcomes Research and Economic …

Webanchor links 2023. 2023. 12. 02 New C2H Report: Efgartigimod Alfa (Vyvgart) 2023. 11. 21 New C2H Report: Valbenazine (Dysval) 2023. 11. 04 New C2H Report: Bimekizumab …

Category: Health Go Health

Abbreviations C2H｜Center for Outcomes Research and …

WebWe collect abbreviations related to health technology assessment (HTA)/cost-effectiveness evaluation.

Category: Health Go Health

Guidelines for analysis of cost-effectiveness evaluation published

WebGuidelines for analysis of cost-effectiveness evaluation published. 2019. 03. 22 In ”Tools,” we have published the “Guideline for Preparing Cost-Effectiveness …

Category: Health Go Health

Full Scale Introduction of Cost-Effectiveness Evaluations in Japan

WebApril 2016~ Trial implementation of cost-effectiveness evaluations. June 2018 In the “Basic Policies on Economic and Fiscal Management and Reform 2018,” it was decided that the …

Category: Health Go Health

C2H1902 Report DLBCL Eng

WebTisagenlecleucel is to be administered via intravenous infusion. The recommended single dose of tisagenlecleucel for DLBCL patients is 0.6 to 6.0 x 108 chimeric antigen receptor …

Category: Health Go Health

Cost-effectiveness evaluation of ravulizumab (Ultomiris) by …

WebThe symptoms used to define BTH (fatigue, abdominal pain, dyspnea, dysphagia, and erectile dysfunction) include subjective factors in patients. Clinical studies did not assure …

Category: Health Go Health